MolNFT v1 · #64639 · protein
Aleglitaar. a new. potent, and balanced dual PPARA/G agonist for the treatment of type II diabetes
3G9E: “Aleglitaar. a new. potent, and balanced dual PPARA/G agonist for the treatment of type II diabetes”. X-ray diffraction. MolNFT v1 #64639 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 3G9E
- Type
- protein
- Length
- 268 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- UniProt
- P37231, Q15788
Structure
x-ray diffraction · 2 distinct chains.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | — | protein | 258 | — | P37231 |
| B | — | protein | 10 | — | Q15788 |
Compared structures
- 3G9E · Aleglitaar. a new. potent, and balanced dual ppara/g agonist for the treatment of type II… · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P37231
- Every structure of UniProt Q15788
- Elsewhere: RCSB PDB 3G9E · PDBe 3G9E · UniProt P37231 · UniProt Q15788
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.